Igc pharma reports second quarter fiscal 2025 results, showcasing progress in its alzheimer's pipeline

Potomac, md / accesswire / november 14, 2024 / igc pharma, inc. ("igc" or the "company") (nyse american:igc) today announced its financial results and strategic advancements for the second fiscal quarter of 2025 ended september30, 2024. the quarter was marked by significant progress in the company's pipeline, particularly in the development of potential treatments for alzheimer's and other neurological and metabolic disorders.
IGC Ratings Summary
IGC Quant Ranking